Related Experiment Video
Updated: May 29, 2026

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
Antiepileptic treatment in pregnant women: morphological and behavioural effects
Torbjörn Tomson1, Dina Battino
1Department of Clinical Neuroscience, Karolinska Institutet, S-171 76 Stockholm, Sweden. torbjorn.tomson@karolinska.se
Insights
Antiepileptic drug (AED) exposure in utero increases risks for birth defects and cognitive issues. Valproate shows higher risks than carbamazepine or lamotrigine, with newer AED data still limited.
Area of Science:
- Obstetrics and Gynecology
- Pediatric Neurology
- Pharmacology
Background:
- Antiepileptic drugs (AEDs) are crucial for managing epilepsy during pregnancy.
- However, in utero exposure to AEDs is linked to adverse pregnancy outcomes.
- Uncontrolled seizures also pose significant risks to both mother and fetus.
Purpose of the Study:
- To review the risks of antiepileptic drugs (AEDs) during pregnancy.
- To compare malformation and cognitive outcomes associated with different AEDs.
- To highlight data gaps for newer generation AEDs.
Main Methods:
- Review of existing literature on AEDs and pregnancy outcomes.
- Analysis of reported rates of major congenital malformations.
- Comparison of cognitive development data following in utero AED exposure.
Main Results:
- AED exposure in utero is associated with increased risks of fetal growth retardation, major congenital malformations, and cognitive impairment.
- Malformation rates range from 4-10%, significantly higher than the general population.
- Valproate exposure is linked to higher malformation rates and potentially poorer cognitive outcomes compared to carbamazepine and lamotrigine.
Conclusions:
- AED treatment is often necessary during pregnancy despite risks.
- Valproate appears to carry higher risks than carbamazepine and lamotrigine.
- More research is needed on newer AEDs regarding pregnancy outcomes.
Abstract:
It is well established that children exposed to antiepileptic drugs (AEDs) in utero have an increased risk of adverse pregnancy outcomes including foetal growth retardation, major congenital malformations and impaired postnatal cognitive development. However, due to the significant maternal and foetal risks associated with uncontrolled epileptic seizures, AED treatment is generally maintained during pregnancy in the majority of women with active epilepsy. The prevalence of major malformations in children exposed to AEDs has ranged from 4 to 10%, 2-4 times higher than in the general population. More recent studies suggest a smaller increase in malformation rates. Malformation rates have consistently been higher in association with exposure to valproate than with carbamazepine and lamotrigine. Some prospective cohort studies also indicate reduced cognitive outcome in children exposed to valproate compared to carbamazepine and possibly lamotrigine. Information on pregnancy outcomes with newer generation AEDs other than lamotrigine are still insufficient.
Related Concept Videos
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...

